HAEMATOLOGICAL AND PARASITOLOGICAL CHANGES IN EXPERIMENTAL ARTEMETHER-TREATED Trypanosoma brucei INFECTION IN RABBITS
DOI:
https://doi.org/10.51406/jnset.v10i1.1331Keywords:
Trypanosoma brucei brucei, rabbit infection, Artemether, haematology, parasitaemiaAbstract
Therapeutic effects and haematological changes by treatment with artemether were investigated and compared with those of diminazene aceturate in Trypanosoma brucei brucei infection of rabbits. Trypanosoma brucei brucei infection of rabbits was characterized by high parasitaemia, acute anaemia and gradual development of leucopenia. T. b. brucei infected rabbits were treated with various doses of artemether, an anti-protozoan drug of malaria and compared with standard dose of diminazene aceturate in other set of rabbits.Though artemether-treated T. b. brucei-infected rabbits were able to survive for 49 to 57 days as against maximum of 39 days in untreated infected group, there was no cure even with high dosage. Diminazene aceturate-treated rabbits were completely cured and had their haematological disorders reversed. Artemether, an anti-protozoan drug against malaria neither could cure the protozoan disease by T. b. brucei in rabbits nor able to reverse the haematological disorder brought about by the parasite but at best slightly prolonged the period of survival of the animals.
Â
References
Cumming, J.N., Ploypradith, P., Gary, H.P. 1997. Antimalarial activity of artmisinin (quighaosu) and related trioxanes: mechanism(s) of action. Advances in Pharmacology, 37: 253-297.
Grant, I.F. 2001. Insecticides for tsetse and trypanosomiasis control: is the environmental risk acceptable? Trends in Parasitology, 17(1): 10-14.
Herbert, W.J., Lumsden, W.R.H. 1976. Trypanosoma brucei a rapid matching method for estimating host parasitaemia. Experimental parasitology, 40: 427-431.
Hursey, B.S. 2000. PAAT: The programme against African trypanosomiasis. Trends Parasitol. P04 (Special Edition).
Jain, N.C. 1986. Schalm’s Veterinary Haematology. 4th edn. Lea and Febiger, Philadelphia, USA.
Lukins, A.G., Dwinger, R.H. 2004. Non-tsetse-transmitted animal trypanosomiasis. In:The Trypanosomiases. Ed, Mandlin, I., Holmes, P. H., Miles, M. A. Cabi Publishing. P 276.
Kenedy, P.G.E. 2004. Human African trypanosomiasis of the CNS: current issues and challenges. The Journal of clinical Investigation, 113: 496-504.
Masiga, D.K., Okech, G., Irungu, P., Ouwa, J., Wekesa, S., Ouwa, B., Guya, S.O. and Ndungu, J.M. 2002. Growth and motality in sheep under high tsetse chalenge in Kenya. Trop. Anim. Health. Prod., 34: 489-501.
Mushina, Y.V., Krisna, V., Haynes, R.K., Meade, J.C. 2007. Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense. In vitro growth. Antimicrobial agents and chemotherapy. Pp. 1852-1854.
Molyleux, D.H. 2000. African Trypanosomiasis. Failure of Science and Public Health in the African Trypanosomiases. In: World Class Parasites, Vol. 1.( Black, S. J. nad Seed, J. R. Eds.), Kluwer Academic Publishers, Dordrecht, pp. 1-10.
Omotainse, S.O., Anosa, V.O. 1992. Erythrocyte response to Trypanosoma brucei in experimentally infected dogs. Revue Élev. Med. vet. Pays trop., 45: 279-283.
Omotainse, S.O., Anosa, V.O. 1995. Leucocyte and thrombocyte responses in dogs experimentally infected with Trypanosoma brucei. Revue Élev. Med. vet. Pays trop., 48(93): 254-258.
Singfrid, M., Veronica, M. Amrose, H., Fransisco, M. 2008. In-vivo trypanocidal activity of atrtemether. http://www.ajol.info/index.php/epj/article/view/43043.
Swallow, B.M. 2000. Impacts of Trypanosomiasis on African agriculture. PATT Technical and Scientific Series 2, Food and Agriculture Organization (FAO), Rome, 52
Taylor, K., Authie, M.L. 2004. Pathogenesis of animal trypanosomiasis. In: The Trypanosomiases. Eds. Maudlin, I., Holmes, P. H. And Miles, M. A. CABI Publishing, UK. Pp: 331-353.
Yuliya, V.M., Sanjev, K., Richard, K.H., John, C.M. 2007. Artemisinins inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense in vitro growth. Antimicrobial agents and chemotherapy. p 1852-1854.
